T. Kojima

发表

Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems

M. Yoshioka, H. Togashi, M. Matsumoto, 2006, Journal of psychopharmacology.

Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and α1-adrenoceptors

O. Kemmotsu, M. Yoshioka, H. Togashi, 2004, Neuroscience Letters.

Circulating endotoxin and (1→3)-β-D-glucan levels during cardiopulmonary bypass and living donor orthotopic liver transplantation

Keiko Ito, S. Gando, Y. Morimoto, 2005 .

Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies.

M. Yoshioka, S. Ohashi, K. Ueno, 2001, The Journal of pharmacology and experimental therapeutics.

[Pulmonary emboli in sclerotherapy for peripheral vascular malformations under general anesthesia; a report of two cases].

Shigeaki Kobayashi, O. Kemmotsu, S. Kaseno, 2004, Masui. The Japanese journal of anesthesiology.

Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: an effect mediated via 5-HT1A receptors

O. Kemmotsu, M. Yoshioka, H. Togashi, 2003, Brain Research.

Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress

M. Yoshioka, H. Togashi, M. Matsumoto, 2005, Psychopharmacology.

Differential characteristics of endogenous serotonin-mediated synaptic transmission in the hippocampal CA1 and CA3 fields of anaesthetized rats

M. Yoshioka, S. Ohashi, K. Ueno, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Different effects of anxiolytic agents, diazepam and 5-HT1A agonist tandospirone, on hippocampal long-term potentiation in vivo

M. Yoshioka, S. Ohashi, K. Ueno, 2001, Pharmacology Biochemistry and Behavior.

Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.

O. Kemmotsu, S. Gando, Y. Morimoto, 2001, Thrombosis research.

Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.

O. Kemmotsu, S. Gando, T. Kojima, 2001, Journal of cardiothoracic and vascular anesthesia.